Intensity Therapeutics | 8-K: Current report
Apr 19 16:07 ET
Intensity Therapeutics | 8-K: Current report
Mar 14 16:20 ET
Intensity Therapeutics | 10-K: Annual report
Mar 14 16:06 ET
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wesolowski John M
Mar 7 18:11 ET
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Leahy Emer
Mar 7 18:06 ET
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GOLDBERG MARK A
Mar 7 18:06 ET
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Donovan Daniel
Mar 7 18:06 ET
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BENDER LEWIS H
Mar 7 18:06 ET
Intensity Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lewis H. Bender(16.1%)
Feb 13 22:25 ET
Intensity Therapeutics | 8-K: Current report
Feb 7 16:18 ET
Intensity Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Dec 12, 2023 08:17 ET
Intensity Therapeutics | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Talamo Joseph
Dec 12, 2023 08:15 ET
Intensity Therapeutics | 8-K: Current report
Dec 12, 2023 08:02 ET
Intensity Therapeutics | 8-K: Current report
Nov 22, 2023 16:30 ET
Intensity Therapeutics | 10-Q: Quarterly report
Nov 13, 2023 12:10 ET
Intensity Therapeutics | 8-K: Intensity Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
Nov 13, 2023 08:02 ET
Intensity Therapeutics | 8-K: Current report
Sep 5, 2023 08:05 ET
Intensity Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Aug 22, 2023 15:37 ET
Intensity Therapeutics | 10-Q/A: Quarterly report (Amendment)
Aug 14, 2023 17:25 ET
Intensity Therapeutics | 10-Q: Quarterly report
Aug 14, 2023 12:45 ET
No Data
No Data